The Influence of Psychological Interventions Upon Disease Progression in HIV-infected Patients Receiving no Medication

Sponsor
Imperial College London (Other)
Overall Status
Completed
CT.gov ID
NCT00180700
Collaborator
Hammersmith Hospitals NHS Trust (Other), Johrei Association (Other)
22
1
2
6
3.7

Study Details

Study Description

Brief Summary

This study examines the hypothesis that psychological interventions have beneficial effects on quality of life including psychological well-being and disease progression in early HIV patients recieving no medication.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Hypnosis
N/A

Detailed Description

Hypothesis: This investigation is based upon the hypothesis that psychological intervention may counteract the detrimental effects of stress both on psychological well-being and on general health.

Background: HIV infection may be considered to be a life-long biological and psychological stressor leading to detrimental outcomes associated with disease progression. Stress reduction in these patients may have beneficial effects through delaying disease progression via the proposed interactive psycho-neuro-endocrine-immune network.

Inclusion Criteria:

HIV infected individuals CD4 T-cell counts above 200 cells/mcl Receiving no anti-retroviral drugs Individuals who signed the informed consent form

Investigative approach: Self-hypnosis and a Japanese non-touching, laying-on-of hands-like technique, called Johrei, were used to investigate the effects of psychological intervention upon immune parameters (especially in CD4 counts) associated with disease progression along with phenomenological associations between stress perception and stress hormone levels in HIV-infected patients receiving no medication.

Study Design

Study Type:
Interventional
Actual Enrollment :
22 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Masking Description:
Single blinded
Primary Purpose:
Other
Official Title:
The Effects of Two Psychological Intervention Techniques, Self-hypnosis and Johrei Healing Method, on Quality of Life, Psychological Well-being, EEG Measures and Various Immunological Measures Including CD4+ Counts in Early HIV: a Randomly Controlled Pilot Study
Actual Study Start Date :
Jun 1, 2003
Actual Primary Completion Date :
Dec 1, 2003
Actual Study Completion Date :
Dec 1, 2003

Arms and Interventions

Arm Intervention/Treatment
Experimental: Self-hypnosis

A course of four weekly 2-hour training sessions coupled with daily self-hypnosis practice was given to 13 participants with diagnosed HIV

Behavioral: Hypnosis

Experimental: Johrei healing method

A course of four weekly 2-hour training sessions coupled with daily self-hypnosis practice was given to 9 participants with diagnosed HIV

Behavioral: Hypnosis

Outcome Measures

Primary Outcome Measures

  1. CD4 T-cell counts [4 weeks]

    Lab test

Secondary Outcome Measures

  1. Other immunological parameters (Viral load levels, NK cell counts) [4 weeks]

  2. Psychological questionnaires (Perceived Stress Scale (PSS), STAI, Beck depression Inventory (BDI)) [4 weeks]

  3. Endogenous hormone levels (cortisol, DHEA-S and melatonin) [4 weeks]

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • HIV infected

  • CD4 T-cell counts above 200 cells/mcl

  • Signed the informed consent form

Exclusion Criteria:
  • receiving anti-retroviral drugs

Contacts and Locations

Locations

Site City State Country Postal Code
1 Imperial College London London England United Kingdom W6 8RP

Sponsors and Collaborators

  • Imperial College London
  • Hammersmith Hospitals NHS Trust
  • Johrei Association

Investigators

  • Principal Investigator: John H Gruzelier, Ph.D., Imperial College London
  • Study Director: Don C Henderson, Ph.D., Imperial College London

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Imperial College London
ClinicalTrials.gov Identifier:
NCT00180700
Other Study ID Numbers:
  • Johrei_HIV1
First Posted:
Sep 16, 2005
Last Update Posted:
Jul 8, 2019
Last Verified:
Jul 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Imperial College London

Study Results

No Results Posted as of Jul 8, 2019